{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T01:47:27Z","timestamp":1777513647577,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.ijantimicag.2005.08.004","type":"journal-article","created":{"date-parts":[[2005,10,5]],"date-time":"2005-10-05T11:07:40Z","timestamp":1128510460000},"page":"373-379","source":"Crossref","is-referenced-by-count":29,"title":["Frequency of isolation and antimicrobial susceptibility of bacteria isolated from bloodstream infections at Children's Medical Center, Tehran, Iran, 1996\u20132000"],"prefix":"10.1016","volume":"26","author":[{"given":"Setareh","family":"Mamishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babak","family":"Pourakbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad H.","family":"Ashtiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad B.","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2005.08.004_bib1","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1128\/JCM.41.8.3655-3660.2003","article-title":"Epidemiology and outcome of nosocomial and community-onset bloodstream infection","volume":"41","author":"Dikekema","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib2","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1086\/513640","article-title":"Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model","volume":"24","author":"Pittet","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/clinids\/5.1.35","article-title":"The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. Laboratory and epidemiologic observations","volume":"5","author":"Weinstein","year":"1983","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib4","unstructured":"American Society for Microbiology Report of the ASM Task Force on Antibiotic Resistance. Antimicrob Agents Chemother 1995;Suppl:1\u201323."},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib5","doi-asserted-by":"crossref","unstructured":"Nosocomial infection rates for interhospital comparison: limitations and possible solutions. A Report from the National Nosocomial Infections Surveillance (NNIS) System. Infect Control Hosp Epidemiol 1991;12:609\u201321.","DOI":"10.2307\/30145247"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib6","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/clind\/24.4.584","article-title":"The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults","volume":"24","author":"Weinstein","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib7","unstructured":"Centers for Disease Control and Prevention. CDC's campaign to prevent antimicrobial resistance in health-care settings. MMWR Morb Mortal Wkly Rep 2002;51:343."},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib8","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1086\/598640","article-title":"Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY antimicrobial surveillance program, 1997","volume":"29","author":"Diekema","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib9","doi-asserted-by":"crossref","unstructured":"National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986\u2013April 1997, issued May 1997. Am J Infect Control 1997;25:477\u201387.","DOI":"10.1016\/S0196-6553(97)90071-7"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib10","series-title":"Clinical microbiology procedures handbook","first-page":"1.19.1","article-title":"Aerobic bacteriology","author":"Pezzlo","year":"1992"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib11","series-title":"Manual of clinical microbiology","first-page":"64","article-title":"Specimen collection","author":"Reisner","year":"1999"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib12","unstructured":"National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A4. Wayne, PA: NCCLS; 1997."},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib13","unstructured":"National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Approved Standard M2-A6. Wayne, PA: NCCLS; 1997."},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib14","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1086\/313710","article-title":"Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998","volume":"30","author":"Fluit","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib15","doi-asserted-by":"crossref","unstructured":"Diekema DJ, Pfaller MA, Jones RN, et al. Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group. Int J Antimicrob Agents 2000;13:257\u201371.","DOI":"10.1016\/S0924-8579(99)00131-4"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM200101043440102","article-title":"Nasal carriage as a source of Staphylococcus aureus bacteraemia","volume":"344","author":"Von Eiff","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-0711-3-7","article-title":"Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002","volume":"3","author":"Karlowsky","year":"2004","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0732-8893(97)00064-3","article-title":"Inducible Amp-C \u03b2-lactamase producing Gram-negative bacilli from bloodstream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE)","volume":"28","author":"Pfaller","year":"1997","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib19","doi-asserted-by":"crossref","unstructured":"Decousser JW, Pina P, Picot F, et al.; ColBVH study group. Frequency of isolation and antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections: a French prospective national survey. J Antimicrob Chemother 2003;51:1213\u201322.","DOI":"10.1093\/jac\/dkg201"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib20","doi-asserted-by":"crossref","unstructured":"Pfaller MA, Jones RN, Doern GV, Kugler K; SENTRY Participant Group. Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada) 1997. Antimicrob Agents Chemother 1998;42:1762\u201370.","DOI":"10.1128\/AAC.42.7.1762"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jac\/42.4.489","article-title":"The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals","volume":"42","author":"Schmitz","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib22","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/jac\/dkg101","article-title":"Antimicrobial resistance in Cairo, Egypt 1999\u20132000: a survey of five hospitals","volume":"51","author":"El Kholy","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0924-8579(98)00058-2","article-title":"Susceptibility patterns of Enterococcus spp. isolated in Poland during 1996","volume":"10","author":"Hryniewicz","year":"1998","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ijantimicag.2004.08.004","article-title":"Drug resistant patterns of enterococci recovered from patients in Tehran during 2000\u20132003","volume":"24","author":"Feizabadi","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib25","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1086\/320185","article-title":"Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997\u20131999","volume":"32","author":"Low","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib26","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/jac\/46.4.639-a","article-title":"Twenty months of screening for glycopeptide-intermediate Staphylococcus aureus","volume":"46","author":"Aucken","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib27","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/jac\/43.6.846","article-title":"Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus in the D\u00fcsseldorf area","volume":"43","author":"Geisel","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib28","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/jac\/dkf212","article-title":"Vancomycin therapeutic drug monitoring: is there a consensus view? The results of a UK National External Quality Assessment Scheme (UK NEQAS) for Antibiotic Assays questionnaire","volume":"50","author":"Tobin","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib29","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1128\/CMR.11.4.628","article-title":"Management of infections due to antibiotic-resistant Streptococcus pneumoniae","volume":"11","author":"Kaplan","year":"1998","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl.","key":"10.1016\/j.ijantimicag.2005.08.004_bib30","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1086\/320182","article-title":"Variations in the prevalence of strains expressing an extended spectrum \u03b2-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region","volume":"32","author":"Winokur","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"Suppl.","key":"10.1016\/j.ijantimicag.2005.08.004_bib31","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1086\/320183","article-title":"Emerging importance of multi-drug resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997\u20131999)","volume":"32","author":"Gales","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1590\/S1413-86702001000100002","article-title":"Multicenter evaluation of resistance patterns of Klebsiella pneumoniae, Escherichia coli, Salmonella spp., and Shigella spp. isolated from clinical specimens in Brazil: RESISTNET Surveillance Program","volume":"5","author":"Oplustil","year":"2001","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib33","unstructured":"Issaragrisil S, Kaufman DW, Anderson T, et al. Low drug attributability of aplastic anemia in Thailand. The Aplastic Anemia Study Group. Blood 1997;89:4034\u20139."},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib34","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/00007611-198609000-00022","article-title":"Chloramphenicol: what we have learned in the last decade","volume":"79","author":"Feder","year":"1986","journal-title":"South Med J"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib35","doi-asserted-by":"crossref","unstructured":"Jones RN, Pfaller MA, Doern GV, Erwin ME, Hollis RJ. Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group. Diagn Microbiol Infect Dis 1998;30:215\u201328.","DOI":"10.1016\/S0732-8893(97)00234-4"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0732-8893(02)00358-9","article-title":"Potency and antimicrobial spectrum update for piperacillin\/tazobactam: emphasis on its activity against resistant organism populations and generally untested species causing community acquired respiratory tract infections","volume":"43","author":"Johnson","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib37","first-page":"196","article-title":"Antimicrobial susceptibility of Klebsiella pneumoniae producing extended spectrum \u03b2-lactamase (ESBL) isolated in hospitals in Brazil","volume":"1","author":"Gales","year":"1997","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.004_bib38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/clinids\/24.2.211","article-title":"Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit","volume":"24","author":"Archibald","year":"1997","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857905002293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857905002293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T11:49:20Z","timestamp":1553687360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857905002293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0924857905002293"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2005.08.004","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}